UY34590A - Fenilimidazopirazoles sustituidos y su uso - Google Patents

Fenilimidazopirazoles sustituidos y su uso

Info

Publication number
UY34590A
UY34590A UY0001034590A UY34590A UY34590A UY 34590 A UY34590 A UY 34590A UY 0001034590 A UY0001034590 A UY 0001034590A UY 34590 A UY34590 A UY 34590A UY 34590 A UY34590 A UY 34590A
Authority
UY
Uruguay
Prior art keywords
phenylimidazopirazoles
replaced
pág
escanear
fórmula
Prior art date
Application number
UY0001034590A
Other languages
English (en)
Spanish (es)
Inventor
Haerter Dr Michael
Telser Dr Joachim
Lobell Dr Mario
Suesmeier Frank
Lindner Niels
Heroult Dr Melanie
Lustig Dr Klemens
Gruenewald Dr Sylvia
Buchmann Dr Bernd
Joerisen Dr Hannah
Kahnert Dr Antje
Original Assignee
Bayer Pharma AG
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47594775&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY34590(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG, Bayer Ip Gmbh filed Critical Bayer Pharma AG
Publication of UY34590A publication Critical patent/UY34590A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
UY0001034590A 2012-01-25 2013-01-23 Fenilimidazopirazoles sustituidos y su uso UY34590A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12152515 2012-01-25

Publications (1)

Publication Number Publication Date
UY34590A true UY34590A (es) 2013-09-02

Family

ID=47594775

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034590A UY34590A (es) 2012-01-25 2013-01-23 Fenilimidazopirazoles sustituidos y su uso

Country Status (30)

Country Link
US (2) US20150005288A1 (enExample)
EP (1) EP2807162B1 (enExample)
JP (1) JP6101290B2 (enExample)
KR (1) KR20140117582A (enExample)
CN (1) CN104411707B (enExample)
AP (1) AP2014007869A0 (enExample)
AR (1) AR089788A1 (enExample)
AU (1) AU2013211707A1 (enExample)
BR (1) BR112014018450A8 (enExample)
CA (1) CA2862163A1 (enExample)
CL (1) CL2014001959A1 (enExample)
CO (1) CO7101244A2 (enExample)
CR (1) CR20140362A (enExample)
CU (1) CU20140096A7 (enExample)
DO (1) DOP2014000173A (enExample)
EA (1) EA201491427A1 (enExample)
EC (1) ECSP14010868A (enExample)
ES (1) ES2639338T3 (enExample)
GT (1) GT201400161A (enExample)
IL (1) IL233652A0 (enExample)
MA (1) MA35877B1 (enExample)
MX (1) MX2014008893A (enExample)
PE (1) PE20142421A1 (enExample)
PH (1) PH12014501687A1 (enExample)
SG (1) SG11201404118XA (enExample)
TN (1) TN2014000320A1 (enExample)
TW (1) TW201343649A (enExample)
UY (1) UY34590A (enExample)
WO (1) WO2013110590A1 (enExample)
ZA (1) ZA201405392B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2862163A1 (en) * 2012-01-25 2013-08-01 Bayer Pharma Aktiengesellschaft Substituted phenylimidazopyrazoles and use thereof
CA3280124A1 (en) 2013-07-31 2025-10-31 Avalyn Pharma Inc. Aerosol imatinib compounds and uses thereof
US20180368404A1 (en) 2014-11-06 2018-12-27 Basf Se 3-pyridyl heterobicyclic compound for controlling invertebrate pests
BR112018007034B1 (pt) * 2015-10-08 2022-10-11 Fmc Corporation Composto, composição, método para controlar uma praga de invertebrados e semente revestida
PY1974629A (es) * 2018-09-13 2021-01-11 Syngenta Participations Ag Compuestos de azol-amida pesticidamente activos
CN109096195A (zh) * 2018-09-27 2018-12-28 上海雅本化学有限公司 一种艾曲波帕的制备方法
KR20220082835A (ko) * 2019-10-16 2022-06-17 바이엘 악티엔게젤샤프트 1,1'-디술판디일비스(4-플루오로-2-메틸-5-니트로벤졸)의 제조 방법
BR112022015110A2 (pt) * 2020-01-29 2022-11-08 Foghorn Therapeutics Inc Compostos e usos dos mesmos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753730B2 (ja) * 1988-07-26 1995-06-07 三共株式会社 イミダゾピラゾール誘導体
UA80171C2 (en) * 2002-12-19 2007-08-27 Pfizer Prod Inc Pyrrolopyrimidine derivatives
US7419978B2 (en) * 2003-10-22 2008-09-02 Bristol-Myers Squibb Company Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
KR101061599B1 (ko) * 2008-12-05 2011-09-02 한국과학기술연구원 비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
CA2765534C (en) * 2009-06-15 2018-09-18 Rigel Pharmaceuticals, Inc. Small molecule inhibitors of spleen tyrosine kinase (syk)
KR101116756B1 (ko) * 2009-10-27 2012-03-13 한국과학기술연구원 단백질 키나아제 저해활성을 갖는 신규의 1,6-치환된 인돌 화합물
CA2862163A1 (en) * 2012-01-25 2013-08-01 Bayer Pharma Aktiengesellschaft Substituted phenylimidazopyrazoles and use thereof

Also Published As

Publication number Publication date
WO2013110590A1 (de) 2013-08-01
GT201400161A (es) 2015-03-05
IL233652A0 (en) 2014-08-31
SG11201404118XA (en) 2014-10-30
ZA201405392B (en) 2015-12-23
US20130190290A1 (en) 2013-07-25
EP2807162B1 (de) 2017-06-07
ECSP14010868A (es) 2015-12-31
CA2862163A1 (en) 2013-08-01
EA201491427A1 (ru) 2015-01-30
TN2014000320A1 (en) 2015-12-21
US20150005288A1 (en) 2015-01-01
CL2014001959A1 (es) 2014-11-07
DOP2014000173A (es) 2014-08-31
CR20140362A (es) 2014-08-21
TW201343649A (zh) 2013-11-01
MA35877B1 (fr) 2014-12-01
EP2807162A1 (de) 2014-12-03
BR112014018450A8 (pt) 2017-07-11
AU2013211707A1 (en) 2014-08-07
PE20142421A1 (es) 2015-01-11
CU20140096A7 (es) 2015-02-26
JP6101290B2 (ja) 2017-03-22
KR20140117582A (ko) 2014-10-07
PH12014501687A1 (en) 2014-10-20
CO7101244A2 (es) 2014-10-31
AP2014007869A0 (en) 2014-08-31
US9394309B2 (en) 2016-07-19
BR112014018450A2 (enExample) 2017-06-20
HK1203198A1 (en) 2015-10-23
MX2014008893A (es) 2014-08-26
JP2015504904A (ja) 2015-02-16
CN104411707A (zh) 2015-03-11
CN104411707B (zh) 2017-03-01
AR089788A1 (es) 2014-09-17
ES2639338T3 (es) 2017-10-26

Similar Documents

Publication Publication Date Title
UY34585A (es) Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
UY34797A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
UY34200A (es) 3-(fluorovinil)pirazoles y su uso
UY34817A (es) Tienopirimidinas
UY34566A (es) 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b
UY34820A (es) Compuestos tipo pirrolo-pirrolidinona
UY34632A (es) Compuestos de oxazolidin- 2- ona y usos de los mismos
UY34484A (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
UY34167A (es) Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos
UY34536A (es) Nucleósidos sustituidos, nucleótidos y análogos de los mismos
UY4169Q (es) Altoparlante
UY34550A (es) Bencilpirazoles sustituidos
UY34541A (es) ?derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina?.
UY34610A (es) Pirroldicarboxamidas condensadas y su uso como agentes farmacéuticos.
UY4210Q (es) Silla
UY34863A (es) Antagonistas de iap
UY4213Q (es) Centro de distribución de energía
UY4223Q (es) Banco
MX369290B (es) Inhibidores de fbx03.
UY34677A (es) Imidazopiridazinas sustituidas
UY34594A (es) Derivados heterocíclicos bicíclicos, su preparación y su aplicación en terapéutica
UY4237Q (es) Taburete
UY4233Q (es) Configuración aplicada en zapato
UY34802A (es) ?suspensión acuosa que contiene polímeros adsorbibles sostenibles, un proceso para prepararla y su uso?.
UY34564A (es) Utilización en terapéutica de derivados de imidazopiridina

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20210526